# Motivational Enhancement Therapy to Improve Adherence to Aromatase Inhibitors

> **NCT02883361** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **University of Calgary**

## Conditions studied

- Breast Cancer
- Medication Adherence

## Interventions

- **BEHAVIORAL:** Motivational enhancement therapy
- **BEHAVIORAL:** Attention Control

## Key facts

- **NCT ID:** NCT02883361
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-08-01
- **Primary completion:** 2020-08-01
- **Final completion:** 2020-08-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Our team decided to conduct more preliminary work on understanding AI adherence to support the optimal development of a randomized controlled trial before proceeding with the trial.
- **Last updated:** 2024-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02883361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02883361, "Motivational Enhancement Therapy to Improve Adherence to Aromatase Inhibitors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02883361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*